Associations between high triglycerides and arterial stiffness in a population-based sample: Kardiovize Brno 2030 study
Language English Country Great Britain, England Media electronic
Document type Journal Article
Grant support
CZ.1.05/1.1.00/02.0123
European Regional Development Fund
316345
7th Framework Program of the European Union
NT13434-4/2012
Ministerstvo Zdravotnictví Ceské Republiky
R01 AG057708
NIA NIH HHS - United States
LQ1605
National Program of Sustainability II (MEYS CR)
PubMed
32669093
PubMed Central
PMC7362636
DOI
10.1186/s12944-020-01345-0
PII: 10.1186/s12944-020-01345-0
Knihovny.cz E-resources
- Keywords
- Atherosclerosis, Cardio-ankle vascular index, Metabolic syndrome, Risk factors, Triglycerides, Vascular stiffness,
- MeSH
- Atherosclerosis blood physiopathology MeSH
- Adult MeSH
- Hypertriglyceridemia blood physiopathology MeSH
- Middle Aged MeSH
- Humans MeSH
- Metabolic Syndrome blood physiopathology MeSH
- Regression Analysis MeSH
- Risk Factors MeSH
- Triglycerides blood MeSH
- Vascular Stiffness physiology MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Triglycerides MeSH
BACKGROUND: The term arterial stiffness (ArSt) describes structural changes in arterial wall related to the loss of elasticity and is known as an independent predictor of cardiovascular diseases (CVD). The evidence relating to ArSt and triglycerides (TG) shows contradictory results. This paper means to survey the association between high TG and ArSt, utilizing the cardio-ankle vascular index (CAVI). METHODS: Subjects aged between 25 and 64 years from a random population-based sample were evaluated between 2013 and 2016. Data from questionnaires, blood pressure, anthropometric measures, and blood samples were collected and analyzed. CAVI was measured using VaSera VS-1500 N devise. Subjects with a history of CVD or chronic renal disease were excluded. RESULTS: One thousand nine hundred thirty-four participants, 44.7% of males, were included. The median age was 48 (Interquartile Range [IQR] 19) years, TG levels were 1.05 (0.793) mmol/L, and CAVI 7.24 (1.43) points. Prevalence of high CAVI was 10.0% (14.5% in males and 6.4% in females; P < 0.001) and prevalence of hypertriglyceridemia was 20.2% (29.2% in males and 13% in females, P < 0.001). The correlation between TG and CAVI was 0.136 (P < 0.001). High CAVI values were more prevalent among participants with metabolic syndrome (MetS), high blood pressure, dysglycemia, abdominal obesity, high LDL-cholesterol (LDL-c), and high total cholesterol. Using binary regression analysis, high TG were associated with high CAVI, even after adjustment for other MetS components, age, gender, smoking status, LDL-c, and statin treatment (β = 0.474, OR = 1.607, 95% CI = 1.063-2.429, P = 0.024). CONCLUSION: TG levels were correlated with ArSt, measured as CAVI. High TG was associated with high CAVI independent of multiple cardiometabolic risk factors. Awareness of the risks and targeted treatment of hypertriglyceridemia could further benefit in reducing the prevalence of CVD and events.
Department of Global Health and Population | Harvard T H Chan School of Public Health Boston USA
Department of Neurology Barrow Neurological Institute Phoenix USA
Department of Public Health Faculty of Medicine Masaryk University Brno Czech Republic
Division of Preventive Cardiology Department of Cardiovascular Medicine Mayo Clinic Rochester MN USA
See more in PubMed
Institute for Health Metrics and Evaluation (IHME). GBD Compare. Seattle, WA:IHME, University of Washington [ http://vizhub.healthdata.org/gbd-compare].
Bonarjee VVS. Arterial stiffness: a prognostic marker in coronary heart disease. Available Methods and Clinical Application. Front Cardiovasc Med. 2018;5:64. doi: 10.3389/fcvm.2018.00064. PubMed DOI PMC
Sato Y, Nagayama D, Ban N, Kawana H, Nagumo A, Ohira M, Endo K, Saiki A, Shirai K, Tatsuno I. Cardio ankle vascular index (CAVI) is an independent predictor of cardiovascular events. Eur Heart J. 2013;34:P1586. doi: 10.1093/eurheartj/eht308.P1586. DOI
Shirai K, Hiruta N, Song M, Kurosu T, Suzuki J, Tomaru T, Miyashita Y, Saiki A, Takahashi M, Suzuki K, Takata M. Cardio-ankle vascular index (CAVI) as a novel indicator of arterial stiffness: theory, evidence and perspectives. J Atheroscler Thromb. 2011;18:924–938. doi: 10.5551/jat.7716. PubMed DOI
Namekata T, Suzuki K, Ishizuka N, Shirai K. Establishing baseline criteria of cardio-ankle vascular index as a new indicator of arteriosclerosis: a cross-sectional study. BMC Cardiovasc Disord. 2011;11:51. doi: 10.1186/1471-2261-11-51. PubMed DOI PMC
Asmar R. Principles and usefulness of the cardio-ankle vascular index (CAVI): a new global arterial stiffness index. Eur Heart J Suppl. 2017;19:B4–B10. doi: 10.1093/eurheartj/suw058. DOI
Takaki A, Ogawa H, Wakeyama T, Iwami T, Kimura M, Hadano Y, Matsuda S, Miyazaki Y, Hiratsuka A, Matsuzaki M. Cardio-ankle vascular index is superior to brachial-ankle pulse wave velocity as an index of arterial stiffness. Hypertens Res. 2008;31:1347–1355. doi: 10.1291/hypres.31.1347. PubMed DOI
Wen J, Huang Y, Lu Y, Yuan H. Associations of non-high-density lipoprotein cholesterol, triglycerides and the total cholesterol/HDL-c ratio with arterial stiffness independent of low-density lipoprotein cholesterol in a Chinese population. Hypertens Res. 2019;42:1223–1230. doi: 10.1038/s41440-019-0251-5. PubMed DOI PMC
Zhan B, Huang X, Wang J, Qin X, Zhang J, Cao J, Song Y, Liu L, Li P, Yang R, et al. Association between lipid profiles and arterial stiffness in Chinese patients with hypertension: insights from the CSPPT. Angiology. 2019;70:515–522. doi: 10.1177/0003319718823341. PubMed DOI
Kubozono T, Miyata M, Ueyama K, Nagaki A, Otsuji Y, Kusano K, Kubozono O, Tei C. Clinical significance and reproducibility of new arterial distensibility index. Circ J. 2007;71:89–94. doi: 10.1253/circj.71.89. PubMed DOI
Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC, Jr, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; world heart federation; international atherosclerosis society; and International Association for the Study of obesity. Circulation. 2009;120:1640–1645. doi: 10.1161/CIRCULATIONAHA.109.192644. PubMed DOI
Nam SH, Kang SG, Lee YA, Song SW, Rho JS. Association of Metabolic Syndrome with the Cardioankle vascular index in asymptomatic Korean population. J Diabetes Res. 2015;2015:328585. doi: 10.1155/2015/328585. PubMed DOI PMC
Yue M, Liu H, He M, Wu F, Li X, Pang Y, Yang X, Zhou G, Ma J, Liu M, et al. Gender-specific association of metabolic syndrome and its components with arterial stiffness in the general Chinese population. PLoS One. 2017;12:e0186863. doi: 10.1371/journal.pone.0186863. PubMed DOI PMC
Liu H, Zhang X, Feng X, Li J, Hu M, Yambe T. Effects of metabolic syndrome on cardio-ankle vascular index in middle-aged and elderly Chinese. Metab Syndr Relat Disord. 2011;9:105–110. doi: 10.1089/met.2010.0019. PubMed DOI
Gomez-Sanchez L, Garcia-Ortiz L, Patino-Alonso MC, Recio-Rodriguez JI, Fernando R, Marti R, Agudo-Conde C, Rodriguez-Sanchez E, Maderuelo-Fernandez JA, Ramos R, et al. Association of metabolic syndrome and its components with arterial stiffness in Caucasian subjects of the MARK study: a cross-sectional trial. Cardiovasc Diabetol. 2016;15:148. doi: 10.1186/s12933-016-0465-7. PubMed DOI PMC
Elosua-Bayes M, Marti-Lluch R, Garcia-Gil MDM, Camos L, Comas-Cufi M, Blanch J, Ponjoan A, Alves-Cabratosa L, Elosua R, Grau M, et al. Association of Classic Cardiovascular Risk Factors and Lifestyles With the Cardio-ankle Vascular Index in a General Mediterranean Population. Rev Esp Cardiol (Engl Ed) 2018;71:458–465. doi: 10.1016/j.recesp.2017.09.004. PubMed DOI
Laucevicius A, Ryliskyte L, Balsyte J, Badariene J, Puronaite R, Navickas R, Solovjova S. Association of cardio-ankle vascular index with cardiovascular risk factors and cardiovascular events in metabolic syndrome patients. Med (Kaunas) 2015;51:152–158. PubMed
Wakabayashi I, Masuda H. Relationships between vascular indexes and atherosclerotic risk factors in patients with type 2 diabetes mellitus. Angiology. 2008;59:567–573. doi: 10.1177/0003319707312517. PubMed DOI
Topouchian J, Labat C, Gautier S, Back M, Achimastos A, Blacher J, Cwynar M, de la Sierra A, Pall D, Fantin F, et al. Effects of metabolic syndrome on arterial function in different age groups: the advanced approach to arterial stiffness study. J Hypertens. 2018;36:824–833. doi: 10.1097/HJH.0000000000001631. PubMed DOI PMC
Wang H, Liu J, Zhao H, Fu X, Shang G, Zhou Y, Yu X, Zhao X, Wang G, Shi H. Arterial stiffness evaluation by cardio-ankle vascular index in hypertension and diabetes mellitus subjects. J Am Soc Hypertens. 2013;7:426–431. doi: 10.1016/j.jash.2013.06.003. PubMed DOI
Zhao X, Bo L, Zhao H, Li L, Zhou Y, Wang H. Cardio-ankle vascular index value in dyslipidemia patients affected by cardiovascular risk factors. Clin Exp Hypertens. 2018;40:312–317. doi: 10.1080/10641963.2017.1377213. PubMed DOI
Wang H, Liu J, Zhao H, Zhao X, Li L, Shi H, Zhan S, Liu J. Relationship between cardio-ankle vascular index and plasma lipids in hypertension subjects. J Hum Hypertens. 2015;29:105–108. doi: 10.1038/jhh.2014.37. PubMed DOI
Nagayama D, Watanabe Y, Saiki A, Shirai K, Tatsuno I. Lipid parameters are independently associated with cardio-ankle vascular index (CAVI) in healthy Japanese subjects. J Atheroscler Thromb. 2018;25:621–633. doi: 10.5551/jat.42291. PubMed DOI PMC
Wang X, Ye P, Cao R, Yang X, Xiao W, Zhang Y, Bai Y, Wu H. Triglycerides are a predictive factor for arterial stiffness: a community-based 4.8-year prospective study. Lipids Health Dis. 2016;15:97. doi: 10.1186/s12944-016-0266-8. PubMed DOI PMC
Hirasada K, Niimura H, Kubozono T, Nakamura A, Tatebo M, Ogawa S, Tsunematsu N, Chiba S, Matsushita T, Kusano K, et al. Values of cardio-ankle vascular index (CAVI) between Amami islands and Kagoshima mainland among health checkup examinees. J Atheroscler Thromb. 2012;19:69–80. doi: 10.5551/jat.6627. PubMed DOI
Movsisyan NK, Vinciguerra M, Lopez-Jimenez F, Kunzova S, Homolka M, Jaresova J, Cifkova R, Sochor O. Kardiovize Brno 2030, a prospective cardiovascular health study in Central Europe: methods, baseline findings and future directions. Eur J Prev Cardiol. 2018;25:54–64. doi: 10.1177/2047487317726623. PubMed DOI
Czech Health Statistics Yearbook 2013 [https://www.uzis.cz/en/publications/czech-health-statistics-yearbook-2013].
Cholesterol test [https://www.mayoclinic.org/tests-procedures/cholesterol-test/about/pac-20384601].
Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, et al. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41:111–188. doi: 10.1093/eurheartj/ehz455. PubMed DOI
Kabutoya T, Kario K. Comparative assessment of cutoffs for the cardio-ankle vascular index and brachial-ankle pulse wave velocity in a Nationwide registry: a cardiovascular prognostic coupling study. Pulse (Basel) 2019;6:131–136. doi: 10.1159/000489604. PubMed DOI PMC
Gomez-Sanchez L, Garcia-Ortiz L, Patino-Alonso MC, Recio-Rodriguez JI, Frontera G, Ramos R, Marti R, Agudo-Conde C, Rodriguez-Sanchez E, Maderuelo-Fernandez JA, et al. The association between the cardio-ankle vascular index and other parameters of vascular structure and function in Caucasian adults: MARK study. J Atheroscler Thromb. 2015;22:901–911. doi: 10.5551/jat.28035. PubMed DOI
Hu H, Cui H, Han W, Ye L, Qiu W, Yang H, Zhang C, Guo X, Mao G. A cutoff point for arterial stiffness using the cardio-ankle vascular index based on carotid arteriosclerosis. Hypertens Res. 2013;36:334–341. doi: 10.1038/hr.2012.192. PubMed DOI
Tanaka A, Tomiyama H, Maruhashi T, Matsuzawa Y, Miyoshi T, Kabutoya T, Kario K, Sugiyama S, Munakata M, Ito H, et al. Physiological Diagnostic Criteria for Vascular Failure. Hypertension. 2018;72:1060–1071. PubMed
Miyoshi T, Ito H. Assessment of arterial stiffness using the cardio-ankle vascular index. Pulse (Basel) 2016;4:11–23. PubMed PMC
Reiner Z, Simental-Mendia LE, Ruscica M, Katsiki N, Banach M, Al Rasadi K, Jamialahmadi T, Sahebkar A. Pulse wave velocity as a measure of arterial stiffness in patients with familial hypercholesterolemia: a systematic review and meta-analysis. Arch Med Sci. 2019;15:1365–1374. doi: 10.5114/aoms.2019.89450. PubMed DOI PMC
Ferrari R, Aguiar C, Alegria E, Bonadonna RC, Cosentino F, Elisaf M, Farnier M, Ferrieres J, Filardi PP, Hancu N, et al. Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia. Eur Heart J Suppl. 2016;18:C2–C12. doi: 10.1093/eurheartj/suw009. PubMed DOI
Reiner Z. Hypertriglyceridaemia and risk of coronary artery disease. Nat Rev Cardiol. 2017;14:401–411. doi: 10.1038/nrcardio.2017.31. PubMed DOI
Lopes-Vicente WRP, Rodrigues S, Cepeda FX, Jordao CP, Costa-Hong V, Dutra-Marques ACB, Carvalho JC, Alves M, Bortolotto LA, Trombetta IC. Arterial stiffness and its association with clustering of metabolic syndrome risk factors. Diabetol Metab Syndr. 2017;9:87. doi: 10.1186/s13098-017-0286-1. PubMed DOI PMC
Pitha J, Kovar J, Blahova T. Fasting and nonfasting triglycerides in cardiovascular and other diseases. Physiol Res. 2015;64:S323–S330. doi: 10.33549/physiolres.933196. PubMed DOI
Sahebkar A, Pecin I, Tedeschi-Reiner E, Derosa G, Maffioli P, Reiner Z. Effects of statin therapy on augmentation index as a measure of arterial stiffness: a systematic review and meta-analysis. Int J Cardiol. 2016;212:160–168. doi: 10.1016/j.ijcard.2016.03.010. PubMed DOI